Written and maintained by CASRAI Editorial Board
Last updated
Ophthalmology is the branch of medicine and surgery devoted to the eyes and the visual system: how they develop, how they fail, how eye disease is detected and classified, and how it is treated and tested. It is both a clinical specialty, practised by physicians called ophthalmologists, and a research field that draws on genetics, immunology, optics, imaging, engineering and clinical trials. This guide explains what ophthalmology covers and how its subspecialties divide the work, then adds the research-administration layer that short definitions leave out: the National Eye Institute (NEI), the main professional and scientific societies, how imaging and gene therapy fit into the research picture, who funds the work, and how the training path is organized. It is educational, not medical advice.
What Is Ophthalmology?
The American Academy of Ophthalmology (AAO) describes ophthalmologists as eye physicians and surgeons: medical doctors trained in the diagnosis, medical management and surgical treatment of eye disease. The word itself comes from Greek roots meaning eye and study. Because ophthalmologists are physicians, their scope includes the eye itself, the tissues around it, and the ways general disease shows up in the eye, as in the eye complications of diabetes or the eye findings in some neurological and inflammatory conditions.
The field is unusual among medical specialties in being organized around a single organ system that is also a window into others. The retina and optic nerve are directly visible to an examiner, which makes the eye a natural site for non-invasive imaging, for early-stage gene and cell therapy research, and for studying neural tissue. This is one reason ophthalmology has an outsized presence in biomedical research relative to the number of practitioners.
Ophthalmology vs. Optometry vs. Vision Science
Three related terms are routinely confused, and the distinction matters for training, licensure, grants and career planning.
- Ophthalmology is a medical and surgical specialty. Ophthalmologists hold a medical (MD) or osteopathic (DO) degree, complete residency training, and can diagnose and treat all eye disease, perform eye surgery and prescribe corrective lenses.
- Optometry is a separate health profession. According to the AAO’s description, optometrists hold a doctor of optometry (OD) degree, perform eye examinations and vision tests, and prescribe and dispense corrective lenses; they are not medical doctors. The scope of what optometrists may treat is set by law and varies by jurisdiction, so check current local rules rather than assuming one answer. Opticians are a third group: technicians who fit eyeglasses and contact lenses from a prescription.
- Vision science is a research discipline, not a clinical profession. It studies how seeing works: optics of the eye, retinal and brain processing, perception, eye movements, development and aging of the visual system. Vision scientists may hold PhDs in neuroscience, psychology, physics, biology or engineering, and many are also clinicians. Their work overlaps with optics and photonics and with cognitive and neural science.
In practice the boundaries are porous. Clinician-scientists, ophthalmologists who also run laboratories, bridge the clinic and the bench, and optometrists contribute to clinical research, particularly on refractive error, contact lenses and ocular surface disease. For a practical look at the clinic side, see CASRAI’s separate supply checklists for an ophthalmology surgery center and an optometry clinic; those cover equipment and consumables, not the discipline itself.
Major Subspecialties
General ophthalmology covers common eye problems and routine care. Beyond it, physicians commonly pursue fellowship training in an area, and research programs are organized along similar lines. The AAO’s own materials mention glaucoma, retina and cornea as examples of fellowship areas. Commonly recognized subspecialty areas include:
- Cornea and external disease: the clear front surface of the eye, ocular surface disease, corneal transplantation.
- Glaucoma: a group of diseases that damage the optic nerve, often associated with eye pressure; medical, laser and surgical management.
- Retina and vitreous: diseases of the light-sensing tissue at the back of the eye, including those linked to diabetes and age, and inherited retinal disease.
- Cataract and refractive surgery: clouding of the lens and procedures that change the eye’s focusing.
- Pediatric ophthalmology and strabismus: eye disease and eye alignment in children.
- Neuro-ophthalmology: vision problems arising from the optic nerve and brain, at the border with neurology.
- Oculoplastics: the eyelids, tear system and orbit.
- Uveitis and ocular immunology: inflammation inside the eye, often linked to systemic immune disease.
- Ocular oncology: tumors of the eye and surrounding tissue, which overlaps with oncology.
Research Areas and Methods
Eye research spans basic, translational and clinical work. Common themes include the cell biology of the retina and cornea, the genetics of inherited eye disease, mechanisms of degeneration and inflammation, myopia and refractive development, visual function after injury, and health-services questions about access to and quality of eye care. The methods below are described in general terms; specific performance claims are deliberately left to the primary literature.
Ophthalmic imaging
The transparency of the eye makes imaging central. Widely used approaches include fundus photography of the retina, optical coherence tomography (OCT), which produces cross-sectional images of retinal layers using light, and fluorescein or related angiography to study blood flow in the retina. Adaptive optics and other advanced methods are used in research settings to visualize structures at fine scale. Imaging supplies both clinical diagnostics and the measurable outcomes that trials depend on. For broader context, see What Is Medical Imaging? and What Is Radiology?, which cover imaging as a discipline more widely than the eye.
Functional testing
Visual acuity charts, visual field testing, measures of eye pressure and electrophysiological tests of retinal function provide structural and functional endpoints. Patient-reported outcome instruments capture how vision affects daily life. As in any trial, the choice of endpoint shapes what a study can show, and regulators and sponsors scrutinise how it is measured.
Gene and cell therapy
The eye has been an early proving ground for gene therapy because it is small, compartmentalised and accessible, and because many inherited retinal diseases trace to single genes. The best-known landmark is Luxturna (voretigene neparvovec-rzyl), a gene therapy made by Spark Therapeutics. According to the U.S. Food and Drug Administration, it is indicated for patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy, and the FDA originally approved it on December 19, 2017. It is regulated as a biologic. Gene therapy for the eye remains a small, specialised area: most eye disease is not caused by a single gene, and treatments are limited to defined genotypes. For the regulatory pathway see FDA Approval for Gene Therapy, and for the modality distinction see Cell Therapy vs. Gene Therapy. Other ocular gene and cell therapy programs exist; consult current trial registries rather than secondary summaries for their status.
Clinical trials
Eye trials follow the same phase structure as other drug and device trials (see Clinical Trial Phases), with some distinct design features: one eye or both eyes may be studied, so analysis must handle correlated measurements from the same person, and treatments are often delivered by injection or implant into the eye rather than by mouth. Statistical planning for such designs is covered in What Is Biostatistics?
The National Eye Institute (NEI)
The NEI is the U.S. federal institute for vision research and part of the National Institutes of Health. It was established in 1968 and states its mission as eliminating vision loss and improving quality of life through vision research. It describes itself as America’s leader in vision research. Its work has two broad parts: an intramural program, in which NEI scientists work in its own labs and branches, and an extramural program, which funds research and training at universities and other institutions through grants and other funding mechanisms. Grant applications to the NEI follow the general NIH process; see NIH Grants: An Overview, the R01 research project grant, and The NIH Grant Cycle. Funding levels, paylines and priorities change from year to year, so check the NEI site and current funding announcements rather than relying on a figure in a guide.
Professional and Scientific Societies
- American Academy of Ophthalmology (AAO). The AAO describes itself as the world’s largest association of eye physicians and surgeons, with a global community of 32,000 medical doctors as stated on its site. It states a mission of protecting sight and empowering lives through patient and public advocacy, ophthalmic education, support for research and advancing the profession. It publishes peer-reviewed journals including Ophthalmology, Ophthalmology Glaucoma, Ophthalmology Retina and Ophthalmology Science. Its history traces to an organization founded in 1896 for eye and ear-nose-throat medicine; the AAO was incorporated as an independent body in 1979.
- Association for Research in Vision and Ophthalmology (ARVO). ARVO is a major international society for vision researchers, bringing together clinicians and basic scientists. CASRAI could not retrieve ARVO’s own pages when this guide was written, so details such as founding date, membership size and journals are not stated here; consult arvo.org for them.
Other national, regional and subspecialty societies exist in most countries, and they typically run meetings, clinical guidelines and fellowship programs.
Journals and Publishing
Eye research appears in specialty journals, including the AAO family listed above, and in general medical and science journals. As with any field, journal metrics differ in meaning and should be read cautiously; CASRAI tracks some of them in its dictionary, for example the JAMA Network impact factor entry, which lists JAMA Ophthalmology among the family’s titles. For choosing and assessing venues in general, see the publishing cluster.
Training Path
The AAO describes the route to becoming an ophthalmologist as a long one, typically 12 to 14 years in total: four years of undergraduate study, four years of medical school (MD or DO), and at least four years of residency in medical and surgical eye care, with some physicians adding one to two years of fellowship in a subspecialty such as glaucoma, retina or cornea. Requirements for licensure and board certification vary by country. Physician-scientists may add research training, such as an NIH career development award (see K Award vs. R01), and vision scientists generally follow a PhD and postdoctoral route instead.
Ophthalmology and Research Administration
Ophthalmic research raises the same administrative questions as other clinical research, with a few emphasised by the specialty. Trials involving devices or biologics need regulatory pathways and sponsor oversight; gene therapy programs add biosafety review and vector manufacturing considerations; imaging-heavy studies need image reading centres, standardised acquisition and data management; and clinic-based studies depend on conflict-of-interest management where physicians have industry ties. Multi-site projects need subaward and effort-reporting discipline like any NIH-funded work. These topics are covered across CASRAI’s guides on grants management, clinical research and integrity and compliance.
Frequently Asked Questions
What does an ophthalmologist do?
An ophthalmologist is a physician who diagnoses and treats eye disease, performs eye surgery and prescribes corrective lenses. Many also conduct research.
What is the difference between an ophthalmologist and an optometrist?
Ophthalmologists are medical doctors (MD or DO) with surgical training. Optometrists hold a doctor of optometry degree, provide eye examinations and vision correction, and are not medical doctors. What optometrists may treat varies by jurisdiction.
What is vision science?
Vision science is the research study of how vision works, from optics to perception. It is not a clinical profession, though many clinicians contribute to it.
What is the National Eye Institute?
The NEI is the U.S. National Institutes of Health institute for vision research, established in 1968, with intramural labs and an extramural grants program.
What is OCT?
Optical coherence tomography is a light-based imaging technique that produces cross-sectional images of the retina and other eye tissues. It is widely used in diagnosis and as a trial endpoint.
Is gene therapy available for eye disease?
For one defined inherited retinal condition linked to biallelic RPE65 mutations, the FDA has approved the gene therapy Luxturna. Most eye diseases are not eligible. This is not medical advice; speak with a qualified clinician about any individual situation.
Is this page medical advice?
No. It describes a field and its research infrastructure. Anyone with questions about their eyes or vision should consult a qualified clinician.
